Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT06755905
NCT06755905CompletedNot Applicable

Application Value of Indocyanine Green Lymphography in Management of Microcystic Lymphatic Malformation of the Tongue

Nanjing Children's Hospital1 site in 1 country42 target enrollmentStarted: January 1, 2019Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
42
Locations
1
Primary Endpoint
Cured (Reduction in dimension greater than 90%)
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

To elucidate the application of indocyanine green (ICG) fluorescence angiography in the treatment of childhood tongue cLM (clinically localized malignancy, presumed context here), providing a clearer scientific basis for subsequent targeted interventions.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
— to 14 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •No previous intervention
  • •more than 6 months post-treatment follow-up
  • •Stage I or Stage IIa

Exclusion Criteria

  • •History of iodine allergy
  • •Syndromic cLM
  • •Severe liver and kidney dysfunction

Outcomes

Primary Outcomes

Cured (Reduction in dimension greater than 90%)

Time Frame: From enrollment to the end of treatment at 12 weeks

Reduction in dimension greater than 90%

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Nanjing Children's Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Tao Han

Clinical Professor

Nanjing Children's Hospital

Study Sites (1)

Loading locations...

Similar Trials

Withdrawn
Phase 4
A Study to Evaluate Indocyanine Green Lymphangiography to Improve Lymphadenectomy in Gastric Cancer PatientsGastric Cancer
NCT04591028Mayo Clinic
Unknown
Phase 1
The Application of Indocyanine-Green(ICG) Fluorescence Imaging in Hepatocellular CarcinomaHepatocellular Carcinoma
NCT03793322Zhujiang Hospital100
Unknown
Not Applicable
The Value of Lymph Node Dissection of Indocyanine Green-guided Near-infrared Fluorescent Imaging in EsophagectomyEsophageal CancerIndocyanine Green
NCT04615806Fujian Medical University Union Hospital40
Completed
Not Applicable
Endoscopic Perfusion Utilizing ICG Fluorescence TechnologyQuality of Life
NCT02383628University of Pittsburgh197
Not yet recruiting
Not Applicable
Clinical application of indocyanine green angiographyPatients who will undergo blood flow reconstruction or vascularized tissue transfer will be included. Patients who are under 15 years old or allergic to any kind of medicine will be excluded.
JPRN-UMIN000017782The University of Tokyo Hospital200